Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 698Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2DEXCEL

02 5EYEPOINT PHARMS

03 3HARROW EYE

04 5OCULAR THERAPEUTIX

05 1SANDOZ

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DEXAMETHASONE

US Patent Number : 11304961

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211379

Patent Use Code : U-3344

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-12-18

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DEXAMETHASONE

US Patent Number : 10537585

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211379

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-12-18

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DEXAMETHASONE

US Patent Number : 10028965

Drug Substance Claim :

Drug Product Claim :

Application Number : 208912

Patent Use Code : U-2340

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-05-23

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DEXAMETHASONE

US Patent Number : 11097061

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208912

Patent Use Code : U-3418

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-06-23

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DEXAMETHASONE

US Patent Number : 10022502

Drug Substance Claim :

Drug Product Claim :

Application Number : 208912

Patent Use Code : U-2340

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-06-22

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DEXAMETHASONE

US Patent Number : 10799642

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208912

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-05-11

blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DEXAMETHASONE

US Patent Number : 10159683

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208912

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-05-23

blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DEXAMETHASONE; TOBRAMYCIN

US Patent Number : 7795316

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50818

Patent Use Code : U-1082

Delist Requested :

Patent Use Description : USE OF A COMBINATION O...

Patent Expiration Date : 2028-08-03

blank

09

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DEXAMETHASONE; TOBRAMYCIN

US Patent Number : 8101582

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50818

Patent Use Code : U-1082

Delist Requested :

Patent Use Description : USE OF A COMBINATION O...

Patent Expiration Date : 2027-12-19

blank

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DEXAMETHASONE; TOBRAMYCIN

US Patent Number : 8450287

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50818

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-12-19

blank